TaiMed Biologics (ROCO:4147) Other Stockholders Equity : NT$-12.3 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Other Stockholders Equity?

TaiMed Biologics's Other Stockholders Equity for the quarter that ended in Mar. 2024 was NT$-12.3 Mil.

TaiMed Biologics's quarterly Other Stockholders Equity declined from Sep. 2023 (NT$3.7 Mil) to Dec. 2023 (NT$-16.1 Mil) but then increased from Dec. 2023 (NT$-16.1 Mil) to Mar. 2024 (NT$-12.3 Mil).

TaiMed Biologics's annual Other Stockholders Equity increased from Dec. 2021 (NT$-36.0 Mil) to Dec. 2022 (NT$-15.8 Mil) but then declined from Dec. 2022 (NT$-15.8 Mil) to Dec. 2023 (NT$-16.1 Mil).

TaiMed Biologics Other Stockholders Equity Historical Data

The historical data trend for TaiMed Biologics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Other Stockholders Equity Chart

TaiMed Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

-11.76

-17.60

-35.97

-15.83

-16.13

TaiMed Biologics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															-17.03	9.03	3.67	-16.13	-12.31

TaiMed Biologics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

TaiMed Biologics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiMed Biologics (ROCO:4147) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492

Website

http://www.taimedbiologics.com

TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines